Harmony Biosciences Ownership 2024 | Who Owns Harmony Biosciences Now?
Institutional Ownership
13.08%
Insider Ownership
19.75%
Retail Ownership
67.17%
Institutional Holders
92.00
Harmony Biosciences Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| VALOR MANAGEMENT LLC | 19.76% | 74.43% | 11,218,033 | - | - | 338,448,056 | Jun 30, 2024 |
| BLACKROCK INC. | 10.28% | 0.00% | 5,835,243 | -87,518 | -1.48% | 176,049,281 | Jun 30, 2024 |
| FMR LLC | 9.23% | 0.01% | 5,237,904 | -17,614 | -0.34% | 158,027,564 | Jun 30, 2024 |
| VANGUARD GROUP INC | 6.20% | 0.00% | 3,519,387 | -108,838 | -3.00% | 106,179,906 | Jun 30, 2024 |
| VIVO CAPITAL, LLC | 4.59% | 7.26% | 2,606,247 | - | - | 78,630,472 | Jun 30, 2024 |
| PACER ADVISORS, INC. | 4.42% | 0.17% | 2,509,609 | 14,695 | 0.59% | 75,714,904 | Jun 30, 2024 |
| STATE STREET CORP | 2.24% | 0.00% | 1,273,498 | -22,046 | -1.70% | 38,421,435,000 | Jun 30, 2024 |
| VENBIO PARTNERS LLC | 1.82% | 13.49% | 1,035,396 | - | - | 31,237,897 | Jun 30, 2024 |
| DIMENSIONAL FUND ADVISORS LP | 1.69% | 0.01% | 956,785 | 112,197 | 13.28% | 28,871,334 | Jun 30, 2024 |
| MORGAN STANLEY | 1.47% | 0.00% | 836,111 | -49,234 | -5.56% | 25,225,470 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.32% | 0.00% | 748,703 | -5,074 | -0.67% | 22,592,800 | Jun 30, 2024 |
| AMERICAN CENTURY COMPANIES INC | 1.20% | 0.01% | 681,536 | 238,140 | 53.71% | 20,561,941 | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 1.05% | 0.03% | 595,800 | 215,700 | 56.75% | 17,975,286 | Jun 30, 2024 |
| LSV ASSET MANAGEMENT | 1.02% | 0.04% | 578,246 | 243,100 | 72.54% | 17,446,000 | Jun 30, 2024 |
| FEDERATED HERMES, INC. | 0.93% | 0.04% | 525,524 | -17 | -0.00% | 15,855,059,000 | Jun 30, 2024 |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 0.92% | 0.00% | 519,701 | 13,547 | 2.68% | 15,679,379 | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | 0.80% | 0.00% | 455,364 | 244,410 | 115.86% | 13,738,331 | Jun 30, 2024 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.66% | 0.00% | 374,708 | 1,192 | 0.32% | 11,304,940 | Jun 30, 2024 |
| NAN FUNG GROUP HOLDINGS LTD | 0.65% | 11.87% | 368,665 | - | - | 11,122,623 | Jun 30, 2024 |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 0.59% | 0.04% | 335,425 | -10,801 | -3.12% | 10,119,772 | Jun 30, 2024 |
Harmony Biosciences's largest institutional shareholder is VALOR MANAGEMENT LLC, holding 19.76% of the company's total share outstanding, currently valued at $338.45M. The top 10 institutional shareholders own together 61.70% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| VALOR MANAGEMENT LLC | 19.76% | 74.43% | 11,218,033 | - | - | 338,448,056 | Jun 30, 2024 |
| VENBIO PARTNERS LLC | 1.82% | 13.49% | 1,035,396 | - | - | 31,237,897 | Jun 30, 2024 |
| NAN FUNG GROUP HOLDINGS LTD | 0.65% | 11.87% | 368,665 | - | - | 11,122,623 | Jun 30, 2024 |
| VIVO CAPITAL, LLC | 4.59% | 7.26% | 2,606,247 | - | - | 78,630,472 | Jun 30, 2024 |
| ALPHACENTRIC ADVISORS LLC | 0.21% | 2.71% | 122,000 | - | - | 3,680,740 | Jun 30, 2024 |
| CUTTER CAPITAL MANAGEMENT, LP | 0.52% | 2.69% | 295,771 | 295,771 | 100.00% | 8,923,411 | Jun 30, 2024 |
| CAPITAL MANAGEMENT CORP /VA | 0.42% | 1.45% | 240,040 | 31,046 | 14.86% | 7,242,007 | Jun 30, 2024 |
| TANG CAPITAL MANAGEMENT LLC | 0.50% | 0.86% | 281,200 | - | - | 8,483,804 | Jun 30, 2024 |
| 683 CAPITAL MANAGEMENT, LLC | 0.52% | 0.67% | 295,000 | - | - | 8,900,150 | Jun 30, 2024 |
| HEALTHINVEST PARTNERS AB | 0.06% | 0.64% | 34,900 | -135,100 | -79.47% | 1,052,933 | Jun 30, 2024 |
| HEDEKER WEALTH, LLC | 0.13% | 0.64% | 72,625 | -5,598 | -7.16% | 2,191,096 | Jun 30, 2024 |
| CITY CENTER ADVISORS, LLC | 0.02% | 0.35% | 8,773 | - | - | 294,597 | Jun 30, 2024 |
| PDT PARTNERS, LLC | 0.15% | 0.25% | 86,168 | - | - | 2,599,689 | Jun 30, 2024 |
| NEW VERNON CAPITAL HOLDINGS II LLC | 0.03% | 0.24% | 14,716 | - | - | 443,982 | Jun 30, 2024 |
| YELIN LAPIDOT HOLDINGS MANAGEMENT LTD. | 0.07% | 0.20% | 37,905 | - | - | 1,143,594 | Jun 30, 2024 |
| ENTRYPOINT CAPITAL, LLC | 0.01% | 0.19% | 4,271 | 363 | 9.29% | 128,856 | Jun 30, 2024 |
| HUSSMAN STRATEGIC ADVISORS, INC. | 0.04% | 0.17% | 21,000 | - | - | 633,570 | Jun 30, 2024 |
| PACER ADVISORS, INC. | 4.42% | 0.17% | 2,509,609 | 14,695 | 0.59% | 75,714,904 | Jun 30, 2024 |
| PRAIRIEWOOD CAPITAL, LLC | 0.02% | 0.16% | 11,442 | - | - | 345,205 | Jun 30, 2024 |
| VIRTUS ETF ADVISERS LLC | 0.02% | 0.16% | 11,067 | -213 | -1.89% | 333,891 | Jun 30, 2024 |
The largest Harmony Biosciences shareholder by % of total assets is VALOR MANAGEMENT LLC. The company owns 11.22M shares of Harmony Biosciences (HRMY), representing 74.43% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| CUTTER CAPITAL MANAGEMENT, LP | 0.52% | 2.69% | 295,771 | 295,771 | 100.00% | 8,923,411 | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | 0.80% | 0.00% | 455,364 | 244,410 | 115.86% | 13,738,331 | Jun 30, 2024 |
| LSV ASSET MANAGEMENT | 1.02% | 0.04% | 578,246 | 243,100 | 72.54% | 17,446,000 | Jun 30, 2024 |
| AMERICAN CENTURY COMPANIES INC | 1.20% | 0.01% | 681,536 | 238,140 | 53.71% | 20,561,941 | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 1.05% | 0.03% | 595,800 | 215,700 | 56.75% | 17,975,286 | Jun 30, 2024 |
| BANK OF AMERICA CORP /DE/ | 0.50% | 0.00% | 283,331 | 209,525 | 283.89% | 8,548,095 | Jun 30, 2024 |
| MARSHALL WACE, LLP | 0.54% | 0.01% | 305,612 | 181,092 | 145.43% | 9,220,315 | Jun 30, 2024 |
| NORGES BANK | 0.23% | 0.00% | 127,988 | 127,988 | 100.00% | 3,861,398 | Jun 30, 2024 |
| DIMENSIONAL FUND ADVISORS LP | 1.69% | 0.01% | 956,785 | 112,197 | 13.28% | 28,871,334 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 0.54% | 0.00% | 307,420 | 104,691 | 51.64% | 9,274,861 | Jun 30, 2024 |
| JPMORGAN CHASE & CO | 0.24% | 0.00% | 136,806 | 93,967 | 219.35% | 4,127,438 | Jun 30, 2024 |
| FIRST TRUST ADVISORS LP | 0.12% | 0.00% | 69,422 | 57,327 | 473.97% | 2,094,461 | Jun 30, 2024 |
| SQUAREPOINT OPS LLC | 0.09% | 0.00% | 50,017 | 50,017 | 100.00% | 1,509,013 | Jun 30, 2024 |
| HRT FINANCIAL LP | 0.06% | 0.01% | 31,780 | 31,780 | 100.00% | 958,000 | Jun 30, 2024 |
| UBS ASSET MANAGEMENT AMERICAS INC | 0.12% | 0.00% | 68,372 | 31,593 | 85.90% | 2,062,784 | Jun 30, 2024 |
| CAPITAL MANAGEMENT CORP /VA | 0.42% | 1.45% | 240,040 | 31,046 | 14.86% | 7,242,007 | Jun 30, 2024 |
| HENNION & WALSH ASSET MANAGEMENT, INC. | 0.08% | 0.07% | 44,945 | 30,638 | 214.15% | 1,355,991 | Jun 30, 2024 |
| D. E. SHAW & CO., INC. | 0.55% | 0.01% | 310,004 | 30,569 | 10.94% | 9,352,820 | Jun 30, 2024 |
| VICTORY CAPITAL MANAGEMENT INC | 0.15% | 0.00% | 84,964 | 29,816 | 54.07% | 2,563,364 | Jun 30, 2024 |
| JEFFERIES FINANCIAL GROUP INC. | 0.09% | 0.02% | 50,500 | 25,000 | 98.04% | 1,523,585 | Jun 30, 2024 |
As of Jun 30 2024, Harmony Biosciences's largest institutional buyer is CUTTER CAPITAL MANAGEMENT, LP. The company purchased 295.77K stocks of HRMY, valued at $8.92M.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| ABRDN PLC | 0.52% | 0.02% | 295,811 | -212,438 | -41.80% | 8,924,618 | Jun 30, 2024 |
| NUVEEN ASSET MANAGEMENT, LLC | 0.36% | 0.00% | 204,158 | -199,211 | -49.39% | 6,159,447 | Jun 30, 2024 |
| SCHRODER INVESTMENT MANAGEMENT GROUP | 0.05% | 0.00% | 29,579 | -147,875 | -83.33% | 892,398 | Jun 30, 2024 |
| HEALTHINVEST PARTNERS AB | 0.06% | 0.64% | 34,900 | -135,100 | -79.47% | 1,052,933 | Jun 30, 2024 |
| VANGUARD GROUP INC | 6.20% | 0.00% | 3,519,387 | -108,838 | -3.00% | 106,179,906 | Jun 30, 2024 |
| PARADIEM, LLC | - | - | - | -93,930 | -100.00% | - | Jun 30, 2024 |
| BLACKROCK INC. | 10.28% | 0.00% | 5,835,243 | -87,518 | -1.48% | 176,049,281 | Jun 30, 2024 |
| CUBIST SYSTEMATIC STRATEGIES, LLC | - | - | - | -63,269 | -100.00% | - | Jun 30, 2024 |
| EDGESTREAM PARTNERS, L.P. | - | - | - | -60,281 | -100.00% | - | Jun 30, 2024 |
| UBS GROUP AG | 0.10% | 0.00% | 55,300 | -58,177 | -51.27% | 1,668,401 | Jun 30, 2024 |
| MORGAN STANLEY | 1.47% | 0.00% | 836,111 | -49,234 | -5.56% | 25,225,470 | Jun 30, 2024 |
| JUMP FINANCIAL, LLC | - | - | - | -37,904 | -100.00% | - | Jun 30, 2024 |
| RUSSELL INVESTMENTS GROUP, LTD. | 0.01% | 0.00% | 7,577 | -26,404 | -77.70% | 228,612 | Jun 30, 2024 |
| ALGERT GLOBAL LLC | 0.18% | 0.10% | 102,611 | -25,000 | -19.59% | 3,096,000 | Jun 30, 2024 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 0.09% | 0.00% | 50,000 | -25,000 | -33.33% | 1,508,500 | Jun 30, 2024 |
| STATE STREET CORP | 2.24% | 0.00% | 1,273,498 | -22,046 | -1.70% | 38,421,435,000 | Jun 30, 2024 |
| BANK OF NEW YORK MELLON CORP | 0.48% | 0.00% | 269,827 | -18,820 | -6.52% | 8,140,692 | Jun 30, 2024 |
| FMR LLC | 9.23% | 0.01% | 5,237,904 | -17,614 | -0.34% | 158,027,564 | Jun 30, 2024 |
| AMERICAN INTERNATIONAL GROUP, INC. | - | - | - | -17,408 | -100.00% | - | Jun 30, 2024 |
| ROYAL BANK OF CANADA | 0.02% | 0.00% | 12,068 | -16,317 | -57.48% | 364,000 | Jun 30, 2024 |
As of Jun 30 2024, Harmony Biosciences's biggest institutional seller is ABRDN PLC. The company sold -0.21M shares of HRMY, valued at $8.92M.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| CUTTER CAPITAL MANAGEMENT, LP | 0.52% | 2.69% | 295,771 | 295,771 | 100.00% | 8,923,411 | Jun 30, 2024 |
| NORGES BANK | 0.23% | 0.00% | 127,988 | 127,988 | 100.00% | 3,861,398 | Jun 30, 2024 |
| SQUAREPOINT OPS LLC | 0.09% | 0.00% | 50,017 | 50,017 | 100.00% | 1,509,013 | Jun 30, 2024 |
| HRT FINANCIAL LP | 0.06% | 0.01% | 31,780 | 31,780 | 100.00% | 958,000 | Jun 30, 2024 |
| VERITION FUND MANAGEMENT LLC | 0.04% | 0.00% | 20,452 | 20,452 | 100.00% | 617,037 | Jun 30, 2024 |
| MARTINGALE ASSET MANAGEMENT L P | 0.03% | 0.01% | 19,837 | 19,837 | 100.00% | 598,483 | Jun 30, 2024 |
| O'SHAUGHNESSY ASSET MANAGEMENT, LLC | 0.03% | 0.01% | 19,239 | 19,239 | 100.00% | 580,441 | Jun 30, 2024 |
| ILLINOIS MUNICIPAL RETIREMENT FUND | 0.03% | 0.01% | 17,866 | 17,866 | 100.00% | 539,017 | Jun 30, 2024 |
| COREBRIDGE FINANCIAL, INC. | 0.03% | 0.00% | 17,584 | 17,584 | 100.00% | 530,509 | Jun 30, 2024 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 0.03% | 0.00% | 16,270 | 16,270 | 100.00% | 490,866 | Jun 30, 2024 |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 0.03% | 0.01% | 15,400 | 15,400 | 100.00% | 464,618 | Jun 30, 2024 |
| DENALI ADVISORS LLC | 0.02% | 0.12% | 14,100 | 14,100 | 100.00% | 425,397 | Jun 30, 2024 |
| BAYESIAN CAPITAL MANAGEMENT, LP | 0.02% | 0.04% | 10,422 | 10,422 | 100.00% | 314,432 | Jun 30, 2024 |
| SCHONFELD STRATEGIC ADVISORS LLC | 0.02% | 0.00% | 9,346 | 9,346 | 100.00% | 281,967 | Jun 30, 2024 |
| SHERBROOKE PARK ADVISERS LLC | 0.02% | 0.05% | 8,643 | 8,643 | 100.00% | 260,759 | Jun 30, 2024 |
| NUMERAI GP LLC | 0.01% | 0.08% | 6,867 | 6,867 | 100.00% | 207,177 | Jun 30, 2024 |
| SIMPLEX TRADING, LLC | 0.01% | 0.00% | 5,569 | 5,569 | 100.00% | 168,000 | Jun 30, 2024 |
| AMUNDI | 0.01% | 0.00% | 4,924 | 4,924 | 100.00% | 152,102 | Jun 30, 2024 |
| BELVEDERE TRADING LLC | 0.01% | 0.00% | 3,955 | 3,955 | 100.00% | 119,322 | Jun 30, 2024 |
| QUARRY LP | 0.00% | 0.02% | 2,052 | 2,052 | 100.00% | 61,909 | Jun 30, 2024 |
| NVERSES CAPITAL, LLC | 0.00% | 0.02% | 1,200 | 1,200 | 100.00% | 36,204 | Jun 30, 2024 |
| SRS CAPITAL ADVISORS, INC. | 0.00% | 0.00% | 112 | 112 | 100.00% | 3,380 | Jun 30, 2024 |
| SWAN CAPITAL LLC | 0.00% | 0.00% | 36 | 36 | 100.00% | 1,086 | Jun 30, 2024 |
| FIRST HORIZON ADVISORS, INC. | 0.00% | - | 34 | 34 | 100.00% | 1,025 | Jun 30, 2024 |
| LARSON FINANCIAL GROUP LLC | - | - | 4 | 4 | 100.00% | 121 | Jun 30, 2024 |
Harmony Biosciences's largest new institutional shareholder by number of shares is CUTTER CAPITAL MANAGEMENT, LP, purchased 295.77K shares, valued at $8.92M, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| PARADIEM, LLC | - | - | - | -93,930 | -100.00% | - | Jun 30, 2024 |
| CUBIST SYSTEMATIC STRATEGIES, LLC | - | - | - | -63,269 | -100.00% | - | Jun 30, 2024 |
| EDGESTREAM PARTNERS, L.P. | - | - | - | -60,281 | -100.00% | - | Jun 30, 2024 |
| JUMP FINANCIAL, LLC | - | - | - | -37,904 | -100.00% | - | Jun 30, 2024 |
| AMERICAN INTERNATIONAL GROUP, INC. | - | - | - | -17,408 | -100.00% | - | Jun 30, 2024 |
| QUANTBOT TECHNOLOGIES LP | - | - | - | -14,809 | -100.00% | - | Jun 30, 2024 |
| NEW YORK LIFE INVESTMENT MANAGEMENT LLC | - | - | - | -11,136 | -100.00% | - | Jun 30, 2024 |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | - | - | - | -8,420 | -100.00% | - | Jun 30, 2024 |
| ELCO MANAGEMENT CO., LLC | - | - | - | -6,955 | -100.00% | - | Jun 30, 2024 |
| CORTON CAPITAL INC. | - | - | - | -6,247 | -100.00% | - | Jun 30, 2024 |
| POINT72 ASIA (SINGAPORE) PTE. LTD. | - | - | - | -3,508 | -100.00% | - | Jun 30, 2024 |
| METROPOLITAN LIFE INSURANCE CO/NY | - | - | - | -1,735 | -100.00% | - | Jun 30, 2024 |
| FINTRUST CAPITAL ADVISORS, LLC | - | - | - | -34 | -100.00% | - | Jun 30, 2024 |
| BELL INVESTMENT ADVISORS, INC | - | - | - | -32 | -100.00% | - | Jun 30, 2024 |
| VENTURI WEALTH MANAGEMENT, LLC | - | - | - | -30 | -100.00% | - | Jun 30, 2024 |
| NELSON, VAN DENBURG & CAMPBELL WEALTH MANAGEMENT GROUP, LLC | - | - | - | -6 | -100.00% | - | Jun 30, 2024 |
| FINANCIAL SYNERGIES WEALTH ADVISORS, INC. | - | - | - | -5 | -100.00% | - | Jun 30, 2024 |
| TFO-TDC, LLC | - | - | - | -1 | -100.00% | - | Jun 30, 2024 |
Harmony Biosciences's largest sold out institutional shareholder by shares sold is PARADIEM, LLC, sold -93.93K shares, valued at -, as of undefined.
Harmony Biosciences Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| SPARROW FUNDS | 0.97% | 3,440 | - | - | Feb 29, 2024 |
| Manager Directed Portfolios | 0.93% | 151,830 | - | - | Jan 31, 2024 |
| HARTFORD HLS SERIES FUND II INC | 0.25% | 62,139 | - | - | Dec 31, 2023 |
| Federated Hermes MDT Series | 0.19% | 478,696 | -4,249 | -0.88% | Jan 31, 2024 |
| CORNERCAP GROUP OF FUNDS /VA/ | 0.14% | 9,856 | - | - | Sep 30, 2022 |
| ROYCE VALUE TRUST, INC. | 0.12% | 94,605 | -12,440 | -11.62% | Mar 31, 2024 |
| HSBC FUNDS | 0.10% | 3,280 | - | - | Jan 31, 2024 |
| FIDELITY MT VERNON STREET TRUST | 0.09% | 2,689,968 | -111,199 | -3.97% | Feb 29, 2024 |
| ALLSPRING VARIABLE TRUST | 0.07% | 44,400 | - | - | Mar 31, 2024 |
| BlackRock Advantage SMID Cap Fund, Inc. | 0.06% | 11,751 | - | - | Mar 28, 2024 |
| SYNTAX ETF TRUST | 0.05% | 1,510 | 450 | 42.45% | Mar 31, 2024 |
| VANGUARD ADMIRAL FUNDS | 0.05% | 199,609 | 23,847 | 13.57% | Feb 29, 2024 |
| VANGUARD VALLEY FORGE FUNDS | 0.04% | 21,970 | - | - | Mar 31, 2024 |
| BlackRock Health Sciences Trust II | 0.04% | 96,975 | - | - | Mar 31, 2024 |
| Pacer Funds Trust | 0.03% | 1,433,678 | 1,433,449 | 625960.26% | Jan 31, 2024 |
| BNY MELLON INDEX FUNDS, INC. | 0.03% | 33,665 | -5,941 | -15.00% | Jan 31, 2024 |
| BNY MELLON INVESTMENT PORTFOLIOS | 0.03% | 16,588 | 36 | 0.22% | Mar 31, 2024 |
| Tributary Funds, Inc. | 0.03% | 137,248 | - | - | Dec 31, 2023 |
| Humankind Benefit Corp | 0.03% | 587 | 96 | 19.55% | Dec 31, 2023 |
| VARIABLE INSURANCE PRODUCTS FUND IV | 0.02% | 60,600 | - | - | Mar 31, 2024 |
| MFS SERIES TRUST I | 0.02% | 333,527 | - | - | Feb 29, 2024 |
| AMERICAN CENTURY MUTUAL FUNDS, INC. | 0.02% | 164,632 | - | - | Jan 31, 2024 |
| abrdn Funds | 0.01% | 188,788 | -9,791 | -4.93% | Jan 31, 2024 |
| DELAWARE GROUP EQUITY FUNDS IV | 0.01% | 14,812 | -15,063 | -50.42% | Mar 28, 2024 |
| Bernstein Fund Inc | 0.01% | 107,300 | -10,360 | -8.81% | Mar 31, 2024 |
| RENAISSANCE CAPITAL GREENWICH FUNDS | 0.01% | 8,622 | - | - | Mar 31, 2024 |
| PFM Multi-Manager Series Trust | 0.01% | 7,941 | 1,472 | 22.75% | Dec 31, 2023 |
| Innovator ETFs Trust | 0.01% | 39,138 | - | - | Jan 31, 2024 |
| QUANTITATIVE MASTER SERIES LLC | 0.01% | 57,593 | -2,475 | -4.12% | Mar 31, 2024 |
| Fidelity Central Investment Portfolios LLC | 0.01% | 440,000 | - | - | Feb 29, 2024 |
| OAK ASSOCIATES FUNDS | 0.01% | 9,450 | - | - | Jan 31, 2024 |
| AMERICAN CENTURY QUANTITATIVE EQUITY FUNDS, INC. | 0.01% | 18,546 | 6,307 | 51.53% | Mar 31, 2024 |
| DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.01% | 4,730 | -250 | -5.02% | Mar 31, 2024 |
| Gabelli Global Small & Mid Cap Value Trust | 0.01% | 700 | - | - | Dec 29, 2023 |
| ROYCE FUND | 0.01% | 48,593 | - | - | Mar 31, 2024 |
| EXCHANGE TRADED CONCEPTS TRUST | 0.01% | 41,941 | 1,965 | 4.92% | Feb 29, 2024 |
| ETFis Series Trust I | 0.01% | 9,657 | 1,147 | 13.48% | Jan 31, 2024 |
| VANGUARD INDEX FUNDS | 0.01% | 2,758,986 | -547,393 | -16.56% | Mar 31, 2024 |
| VALUED ADVISERS TRUST | 0.01% | 5,801 | - | - | Jan 31, 2024 |
| HUSSMAN INVESTMENT TRUST | 0.01% | 21,000 | -10,000 | -32.26% | Dec 31, 2023 |
| FIDELITY COMMONWEALTH TRUST | 0.01% | 17,869 | 279 | 1.59% | Feb 29, 2024 |
| AIM GROWTH SERIES (INVESCO GROWTH SERIES) | 0.01% | 167,010 | - | - | Mar 31, 2024 |
| IndexIQ ETF Trust | 0.00% | 9,958 | -702 | -6.59% | Jan 31, 2024 |
| RBB Fund Trust | 0.00% | 4,033 | - | - | Feb 29, 2024 |
| North Square Investments Trust | 0.00% | 37,300 | -660 | -1.74% | Feb 29, 2024 |
| Pear Tree Funds | 0.00% | 28,500 | - | - | Mar 31, 2024 |
| AMERICAN CENTURY ETF TRUST | 0.00% | 396,005 | 242,217 | 157.50% | Feb 29, 2024 |
| FIDELITY SELECT PORTFOLIOS | 0.00% | 222,602 | 25,900 | 13.17% | Feb 29, 2024 |
| Nushares ETF Trust | 0.00% | 25,212 | - | - | Jan 31, 2024 |
| SCHWAB CAPITAL TRUST | 0.00% | 143,033 | 29,956 | 26.49% | Jan 31, 2024 |
| FundVantage Trust | 0.00% | 53,263 | 2,059 | 4.02% | Mar 28, 2024 |
| FORUM FUNDS | 0.00% | 7,680 | - | - | Jan 31, 2024 |
| TrimTabs ETF Trust | 0.00% | 2,166 | 2,166 | - | Jan 31, 2024 |
| MFS VARIABLE INSURANCE TRUST | 0.00% | 97,646 | 547 | 0.56% | Mar 31, 2024 |
| FIRST TRUST EXCHANGE-TRADED ALPHADEX FUND | 0.00% | 11,090 | -23,068 | -67.53% | Jan 31, 2024 |
| TIAA SEPARATE ACCOUNT VA 1 | 0.00% | 588 | - | - | Mar 31, 2024 |
| FIRST TRUST EXCHANGE-TRADED FUND | 0.00% | 24,289 | - | - | Mar 31, 2024 |
| BNY Mellon Strategic Funds, Inc. | 0.00% | 5,244 | - | - | Mar 31, 2024 |
| Securian Funds Trust | 0.00% | 22,713 | -17,556 | -43.60% | Mar 31, 2024 |
| GOLDMAN SACHS VARIABLE INSURANCE TRUST | 0.00% | 8,175 | - | - | Mar 31, 2024 |
| JANUS INVESTMENT FUND | 0.00% | 596,828 | - | - | Dec 31, 2023 |
| UNIFIED SERIES TRUST | 0.00% | 30,000 | 4,000 | 15.38% | Feb 29, 2024 |
| AIM COUNSELOR SERIES TRUST (INVESCO COUNSELOR SERIES TRUST) | 0.00% | 439,457 | - | - | Feb 29, 2024 |
| Legg Mason ETF Investment Trust | 0.00% | 3,633 | 1,075 | 42.03% | Mar 31, 2024 |
| FIDELITY PURITAN TRUST | 0.00% | 92,652 | - | - | Jan 31, 2024 |
| Principal Exchange-Traded Funds | 0.00% | 21,178 | -6,330 | -23.01% | Mar 31, 2024 |
| TIAA-CREF LIFE FUNDS | 0.00% | 4,661 | -147 | -3.06% | Mar 31, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 326,485 | 3,595 | 1.11% | Feb 29, 2024 |
| TIMOTHY PLAN | 0.00% | 7,293 | 981 | 15.54% | Mar 31, 2024 |
| Lattice Strategies Trust | 0.00% | 2,102 | -379 | -15.28% | Mar 31, 2024 |
| Ivy Variable Insurance Portfolios | 0.00% | 31,385 | -24,901 | -44.24% | Mar 28, 2024 |
| Columbia Funds Variable Series Trust II | 0.00% | 42,000 | - | - | Mar 31, 2024 |
| VANGUARD TAX-MANAGED FUNDS | 0.00% | 251,671 | -4,581 | -1.79% | Mar 31, 2024 |
| Calvert Variable Products, Inc. | 0.00% | 3,278 | - | - | Mar 31, 2024 |
| AdvisorShares Trust | 0.00% | 4,630 | - | - | Mar 28, 2024 |
| AMERICAN CENTURY WORLD MUTUAL FUNDS INC | 0.00% | 11,973 | - | - | Feb 29, 2024 |
| Federated Hermes Equity Funds | 0.00% | 21,546 | - | - | Mar 31, 2024 |
| CALAMOS INVESTMENT TRUST/IL | 0.00% | 109,268 | - | - | Jan 31, 2024 |
| FIDELITY COVINGTON TRUST | 0.00% | 17,241 | -1,633 | -8.65% | Jan 31, 2024 |
| SHELTON FUNDS | 0.00% | 1,410 | - | - | Feb 29, 2024 |
| Voya VARIABLE PORTFOLIOS INC | 0.00% | 26,399 | 1,266 | 5.04% | Mar 31, 2024 |
| STEWARD FUNDS, INC. | 0.00% | 1,869 | - | - | Jan 31, 2024 |
| ALPS ETF Trust | 0.00% | 8,107 | -571 | -6.58% | Feb 29, 2024 |
| Dimensional ETF Trust | 0.00% | 276,795 | 22,313 | 8.77% | Jan 31, 2024 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 18,439 | -4,808 | -20.68% | Mar 31, 2024 |
| IVY FUNDS | 0.00% | 194,863 | -185,368 | -48.75% | Mar 28, 2024 |
| FIRST TRUST EXCHANGE-TRADED FUND VI | 0.00% | 2,985 | - | - | Mar 31, 2024 |
| Catholic Responsible Investments Funds | 0.00% | 19,722 | 1,021 | 5.46% | Jan 31, 2024 |
| PUTNAM FUNDS TRUST | 0.00% | 110,200 | - | - | Jan 31, 2024 |
| VANGUARD HORIZON FUNDS | 0.00% | 11,979 | - | - | Mar 31, 2024 |
| VANGUARD WORLD FUND | 0.00% | 118,308 | -10,106 | -7.87% | Feb 29, 2024 |
| GPS Funds I | 0.00% | 2,539 | - | - | Mar 31, 2024 |
| WILLIAM BLAIR FUNDS | 0.00% | 45,007 | - | - | Mar 31, 2024 |
| ProFunds | 0.00% | 5,183 | -3,557 | -40.70% | Mar 31, 2024 |
| ALLIANZ VARIABLE INSURANCE PRODUCTS TRUST | 0.00% | 24,198 | -1,397 | -5.46% | Dec 31, 2023 |
| PRAXIS MUTUAL FUNDS | 0.00% | 4,890 | 290 | 6.30% | Dec 31, 2023 |
| PRUDENTIAL SERIES FUND | 0.00% | 34,179 | -500 | -1.44% | Mar 28, 2024 |
| OHIO NATIONAL FUND INC | 0.00% | 8,481 | -237 | -2.72% | Mar 31, 2024 |
| STERLING CAPITAL FUNDS | 0.00% | 8,920 | - | - | Mar 28, 2024 |
| Series Portfolios Trust | 0.00% | 2,558 | - | - | Jan 31, 2024 |
Harmony Biosciences's largest mutual fund holder by % of total assets is "SPARROW FUNDS", owning 3.44K shares, compromising 0.97% of its total assets.
Harmony Biosciences Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 30 Jun, 24 | 92 | -55.98% |
| 31 Mar, 24 | 209 | -6.70% |
| 31 Dec, 23 | 224 | 7.69% |
| 30 Sep, 23 | 208 | -1.89% |
| 30 Jun, 23 | 212 | -4.93% |
| 31 Mar, 23 | 223 | -8.23% |
| 31 Dec, 22 | 243 | 21.50% |
| 30 Sep, 22 | 200 | 11.73% |
| 30 Jun, 22 | 179 | 2.87% |
| 31 Mar, 22 | 174 | 21.68% |
| 31 Dec, 21 | 143 | 44.44% |
| 30 Sep, 21 | 99 | 23.75% |
| 30 Jun, 21 | 80 | 42.86% |
| 31 Mar, 21 | 56 | -5.08% |
| 31 Dec, 20 | 59 | 34.09% |
| 30 Sep, 20 | 44 | - |
As of 30 Jun 24, 92 institutions are holding Harmony Biosciences's shares, representing a decrease of -55.98% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 30 Jun, 24 | 7,422,972 | -84.79% |
| 31 Mar, 24 | 48,809,647 | 2.10% |
| 31 Dec, 23 | 47,804,048 | -3.08% |
| 30 Sep, 23 | 49,324,058 | -4.73% |
| 30 Jun, 23 | 51,774,016 | 0.63% |
| 31 Mar, 23 | 51,450,487 | 0.20% |
| 31 Dec, 22 | 51,348,622 | 1.49% |
| 30 Sep, 22 | 50,597,043 | 5.69% |
| 30 Jun, 22 | 47,872,710 | 3.79% |
| 31 Mar, 22 | 46,126,352 | 3.49% |
| 31 Dec, 21 | 44,570,432 | 44.09% |
| 30 Sep, 21 | 30,932,323 | 10.49% |
| 30 Jun, 21 | 27,994,383 | 1.91% |
| 31 Mar, 21 | 27,468,710 | -1.74% |
| 31 Dec, 20 | 27,956,367 | -2.08% |
| 30 Sep, 20 | 28,549,056 | - |
Harmony Biosciences (HRMY) has 7.42M shares outstanding as of 30 Jun 24, down -84.79% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 30 Jun, 24 | 13.08% | 0.19% |
| 31 Mar, 24 | 82.07% | 1.29% |
| 31 Dec, 23 | 79.86% | 1.18% |
| 30 Sep, 23 | 82.24% | 1.09% |
| 30 Jun, 23 | 86.68% | 1.17% |
| 31 Mar, 23 | 86.14% | 1.16% |
| 31 Dec, 22 | 86.33% | 1.18% |
| 30 Sep, 22 | 85.42% | 1.30% |
| 30 Jun, 22 | 81.05% | 1.32% |
| 31 Mar, 22 | 78.30% | 1.30% |
| 31 Dec, 21 | 77.47% | 2.70% |
| 30 Sep, 21 | 53.59% | 2.22% |
| 30 Jun, 21 | 49.16% | 2.11% |
| 31 Mar, 21 | 48.28% | 2.00% |
| 31 Dec, 20 | 49.14% | 0.55% |
| 30 Sep, 20 | 94.49% | - |
As of 30 Jun 24, Harmony Biosciences is held by 13.08% institutional shareholders, representing a 0.19% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 44 | -51.65% |
| 31 Mar, 24 | 91 | -21.55% |
| 31 Dec, 23 | 116 | -0.85% |
| 30 Sep, 23 | 117 | -0.85% |
| 30 Jun, 23 | 118 | 2.61% |
| 31 Mar, 23 | 115 | -23.33% |
| 31 Dec, 22 | 150 | 2.04% |
| 30 Sep, 22 | 147 | 50.00% |
| 30 Jun, 22 | 98 | -13.27% |
| 31 Mar, 22 | 113 | 17.71% |
| 31 Dec, 21 | 96 | 68.42% |
| 30 Sep, 21 | 57 | -6.56% |
| 30 Jun, 21 | 61 | 96.77% |
| 31 Mar, 21 | 31 | -26.19% |
| 31 Dec, 20 | 42 | -4.55% |
| 30 Sep, 20 | 44 | - |
44 institutional shareholders have increased their position in HRMY stock as of 30 Jun 24 compared to 91 in the previous quarter (a -51.65% decrease).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 29 | -63.75% |
| 31 Mar, 24 | 80 | 5.26% |
| 31 Dec, 23 | 76 | 33.33% |
| 30 Sep, 23 | 57 | -10.94% |
| 30 Jun, 23 | 64 | -20.00% |
| 31 Mar, 23 | 80 | 19.40% |
| 31 Dec, 22 | 67 | 109.38% |
| 30 Sep, 22 | 32 | -47.54% |
| 30 Jun, 22 | 61 | 45.24% |
| 31 Mar, 22 | 42 | 35.48% |
| 31 Dec, 21 | 31 | 6.90% |
| 30 Sep, 21 | 29 | 222.22% |
| 30 Jun, 21 | 9 | -40.00% |
| 31 Mar, 21 | 15 | 25.00% |
| 31 Dec, 20 | 12 | - |
| 30 Sep, 20 | - | - |
29 institutional shareholders have reduced their position in HRMY stock as of 30 Jun 24 compared to 80 in the previous quarter (a -63.75% decrease).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Jun, 24 | 92 | -55.98% | 7,422,972 | -84.79% | 13.08% | 0.19% | 44 | -51.65% | 29 | -63.75% |
| 31 Mar, 24 | 209 | -6.70% | 48,809,647 | 2.10% | 82.07% | 1.29% | 91 | -21.55% | 80 | 5.26% |
| 31 Dec, 23 | 224 | 7.69% | 47,804,048 | -3.08% | 79.86% | 1.18% | 116 | -0.85% | 76 | 33.33% |
| 30 Sep, 23 | 208 | -1.89% | 49,324,058 | -4.73% | 82.24% | 1.09% | 117 | -0.85% | 57 | -10.94% |
| 30 Jun, 23 | 212 | -4.93% | 51,774,016 | 0.63% | 86.68% | 1.17% | 118 | 2.61% | 64 | -20.00% |
| 31 Mar, 23 | 223 | -8.23% | 51,450,487 | 0.20% | 86.14% | 1.16% | 115 | -23.33% | 80 | 19.40% |
| 31 Dec, 22 | 243 | 21.50% | 51,348,622 | 1.49% | 86.33% | 1.18% | 150 | 2.04% | 67 | 109.38% |
| 30 Sep, 22 | 200 | 11.73% | 50,597,043 | 5.69% | 85.42% | 1.30% | 147 | 50.00% | 32 | -47.54% |
| 30 Jun, 22 | 179 | 2.87% | 47,872,710 | 3.79% | 81.05% | 1.32% | 98 | -13.27% | 61 | 45.24% |
| 31 Mar, 22 | 174 | 21.68% | 46,126,352 | 3.49% | 78.30% | 1.30% | 113 | 17.71% | 42 | 35.48% |
| 31 Dec, 21 | 143 | 44.44% | 44,570,432 | 44.09% | 77.47% | 2.70% | 96 | 68.42% | 31 | 6.90% |
| 30 Sep, 21 | 99 | 23.75% | 30,932,323 | 10.49% | 53.59% | 2.22% | 57 | -6.56% | 29 | 222.22% |
| 30 Jun, 21 | 80 | 42.86% | 27,994,383 | 1.91% | 49.16% | 2.11% | 61 | 96.77% | 9 | -40.00% |
| 31 Mar, 21 | 56 | -5.08% | 27,468,710 | -1.74% | 48.28% | 2.00% | 31 | -26.19% | 15 | 25.00% |
| 31 Dec, 20 | 59 | 34.09% | 27,956,367 | -2.08% | 49.14% | 0.55% | 42 | -4.55% | 12 | - |
| 30 Sep, 20 | 44 | - | 28,549,056 | - | 94.49% | - | 44 | - | - | - |
Harmony Biosciences Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Insider Sells
All Insider Owners Trades
The last insider sell of Harmony Biosciences's stock was made by Kapadia Sandip on Apr 02 2024, selling 15,000 shares at - per share (valued at -).
Harmony Biosciences Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q2 2024 | 9 | - | - |
| Q1 2024 | 13 | 8 | 162.50% |
| Q4 2023 | 3 | - | - |
| Q2 2023 | 8 | 2 | 400.00% |
| Q1 2023 | 1 | 2 | 50.00% |
| Q4 2022 | 4 | 36 | 11.11% |
| Q3 2022 | - | 12 | - |
| Q2 2022 | 8 | 13 | 61.54% |
| Q1 2022 | 7 | 31 | 22.58% |
| Q4 2021 | 10 | 20 | 50.00% |
| Q3 2021 | 10 | 22 | 45.45% |
| Q2 2021 | 8 | 2 | 400.00% |
| Q1 2021 | 2 | - | - |
| Q4 2020 | 2 | - | - |
| Q3 2020 | 28 | 28 | 100.00% |
9 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by Harmony Biosciences's insiders, as of Q2 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q2 2024 | - | - | - |
| Q1 2024 | - | 2 | - |
| Q4 2023 | - | - | - |
| Q2 2023 | - | - | - |
| Q1 2023 | - | - | - |
| Q4 2022 | - | 31 | - |
| Q3 2022 | - | 10 | - |
| Q2 2022 | - | 10 | - |
| Q1 2022 | - | 19 | - |
| Q4 2021 | - | 13 | - |
| Q3 2021 | - | 11 | - |
| Q2 2021 | - | 1 | - |
| Q1 2021 | - | - | - |
| Q4 2020 | - | - | - |
| Q3 2020 | 8 | - | - |
As of Q2 2024, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Harmony Biosciences's stocks.
Harmony Biosciences Peer Ownership
| Ticker | Company |
|---|---|
| PLRX | Pliant Therapeutics, Inc. |
| NUVL | Nuvalent, Inc. |
| GOSS | Gossamer Bio, Inc. |
| IDYA | IDEAYA Biosciences, Inc. |
| RVMD | Revolution Medicines, Inc. Warrant |
| VRDN | Viridian Therapeutics, Inc. |
| EWTX | Edgewise Therapeutics, Inc. |
| VTYX | Ventyx Biosciences, Inc. |
| CERE | Cerevel Therapeutics Holdings, Inc. |
| TVTX | Travere Therapeutics, Inc. |
| FENC | Fennec Pharmaceuticals Inc. |
| REPL | Replimune Group, Inc. |
| SNDX | Syndax Pharmaceuticals, Inc. |
| JANX | Janux Therapeutics, Inc. |
| KRON | Kronos Bio, Inc. |
| INZY | Inozyme Pharma, Inc. |
| KROS | Keros Therapeutics, Inc. |
| GPCR | Structure Therapeutics Inc. |
| PTGX | Protagonist Therapeutics, Inc. |
| LYRA | Lyra Therapeutics, Inc. |
| NVCT | Nuvectis Pharma, Inc. |
| VRNA | Verona Pharma plc |
HRMY Ownership FAQ
Who Owns Harmony Biosciences?
Harmony Biosciences is owned by institutional shareholders (13.08%), insiders (19.75%), and public (67.17%). The largest institutional shareholder of Harmony Biosciences is VALOR MANAGEMENT LLC (19.76% of total shares) and the top mutual fund owner is SPARROW FUNDS (0.97% of total shares).
Who are the major institutional shareholders of Harmony Biosciences?
Harmony Biosciences's major institutional shareholders are VALOR MANAGEMENT LLC, BLACKROCK INC., FMR LLC, VANGUARD GROUP INC, and VIVO CAPITAL, LLC. The top five shareholders own together 50.05% of the company's share outstanding.
How many Harmony Biosciences shareholders are there?
As of Jun 2024, there are 92 institutional shareholders of Harmony Biosciences.
What percentage of Harmony Biosciences is owned by VALOR MANAGEMENT LLC?
VALOR MANAGEMENT LLC owns 11.22M shares of Harmony Biosciences, representing 19.76% of the company's total shares outstanding, valued at $338.45M (as of Jun 2024).
What percentage of Harmony Biosciences is owned by BLACKROCK INC?
As of Jun 2024, BLACKROCK INC holds 5.84M shares of Harmony Biosciences (HRMY), compromising 10.28% of the company, valued at $176.05M.
What percentage of Harmony Biosciences is owned by FMR LLC?
FMR LLC is the third largest holder of Harmony Biosciences. The company owns 5.24M of the company's shares outstanding (worth $158.03M).